Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-07-15
2008-07-15
Kaushal, Sumesh (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093100, C424S093200, C424S093600, C435S320100, C435S325000, C435S455000
Reexamination Certificate
active
07399750
ABSTRACT:
Methods for the delivery of genes to improve cardiac function including the use of viral vectors, isolation of the heart from systemic circulation, and induction of hypothermia/cardiac arrest are described. The method results in high-level, long-term expression of reporter genes and enhanced cardiac function in hamster models of heart disease.
REFERENCES:
patent: 5652122 (1997-07-01), Frankel et al.
patent: 2753722 (1998-03-01), None
patent: WO 97/37224 (1997-10-01), None
patent: WO 99/30696 (1999-06-01), None
patent: WO 00/25804 (2000-05-01), None
Armand et al Cardiovasc Res. 62(3):439-41. 2004.
Janczewski et al Cardiovasc Res. 62(3):468-80, 2004.
Juengst BMJ, 326:1410-11, 2003.
Check Nature 422:7, 2003.
Couzin et al, Science 307:1028, 2005.
Rosenberg et al, Science 287:1751, 2000.
Anderson, Nature 392:25-30, 1998.
Touchette, Nat. Med. 2(1) 7-8, 1996.
Chien et al Nat Med. 9(5):508-9, 2003.
Lip et al, BMJ 320:104-107, 2000.
Iwanaga et al, Chronic phospholamban inhibition progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest. 113(5):727-36, 2004.
Hoshijima et al, Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med. 8(8):864-71, 2002.
Dillmann, Wolfgang, Influences of Increased Expression of the Ca2+ATPase of the Sarcoplasmic Reticulum by a Transgenic Approach on Cardiac Contractility. Annals New York Academy of Sciences, pp. 43-48, 1998.
Donahue, J. Kevin et al. Ultrarapid, highly efficient viral gene transfer to the heart. Proc.Natl.Acad.Sci. USA vol. 94, 4664-4668, 1997.
He, Huaping et al. Effects of Mutant and Antisense RNA of Phospholamban on SR CA2+-ATPase Activity and Cardiac Myocyte Contractility. Circulation, 974-980, 1999.
He, Huaping et al. Influence of an Antisense Phospholamban Transcribed by an Adenoviral Vector on Ca2+ATPase in Cardiac Myocytes. Journal of Molecular and Cellular Cardiology, vol. 29, No. 6, A181, 1997.
Ikeda, Yasuhiro et al. In Vivo Gene Transfer of Deficient δ-Sarcoglycan Protein in BIO14.6 Cardiomyopathic Hamster Hearts. Circulation, 313, 2000.
Koss, Kimberly et al. Phospholamban: A Prominent Regulator of Myocardial Contractility. Circulation Research, vol. 79. No. 6, 1059-1063, 1996.
Logeart, Damien et al. Highly Efficient Adenovirus-Mediated Gene Transfer to Cardiac Myocytes after Single-Pass Coronary Delivery. Human Gene Therapy 11:1015-1022, 2000.
Logeart, Damien et al. How to Optimize In Vivo Gene Transfer to Cardiac Myocotes: Mechanical or Pharmacological Procedures? Human Gene Therapy 12:1601-1610, 2001.
Toyofuku, Toshihiko et al. Amino Acids Glu2to Ile18in the Cytoplasmic Domain of Pospholamban Are Essential for Functional Association with the Ca2+-ATPase of Sarcoplasmic Reticulum. The Journal of Biological Chemistry, vol. 269, No. 4, 3088-3094, 1994.
Arber, S., et al (1997) MLP-deficient mice exhibit a diruption of cardiac cytoarchitechtural organization, dilated cardiomyopathy, and heart failure.Cell. 88:393-403.
Christensen, G. et al. (2000) High-Efficiency, Long-term cardiac expression of foreign genes in living mouse embryos and neonates.Circulation. 101:178-84.
Coral-Vazquez, R. et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy.Cell. 98:465-74.
French, B.A. et al. (1994) Direct in vivo transfer into porine myocardium using replication-deficient adenoviral vectors.Circulation. 90:2414-24.
Frommes, Y. et al. (1999) Gene delivery in the myocardium by intrapericardial injection.Gene Ther. 6:683-8.
Greelish, J.P. et al. (1999) Stable restoration of the sarcoglycam complex in dystrophic muscle perfused wih histamine and recombinant adeno-associated viral vector.Nat. med. 5:439-43.
Gutzman, R.J. et al. (1993) Efficient gene transfer into myocardium by direct injection of adenovirus vectors.Cric. Res. 73:1202-7.
Hajjar, R.J. et al. (1998) Modulation of ventricular function through gene transferin vivo. Proc. Natl. Acad. Sci., USA. 95:5251-5256.
Holt, K.M. et al. (1998) Functional rescue of the sarcoglycam complex in BIO 14.6 hamster using delta-sarcoglycan gene transfer.Mol. Cell. 1:841-8.
Johnson, L.G. (1992) Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis.Nat. Genet. 2:21-5.
Kaplitt, M.G. et al. (1996) Long-term gene transfer in procine myocardium aftercoronary infusion of an adeno-associated virus vector.Ann. Thorac. Surg. 62:1669-76.
Maeda, Y., et al. (1998) Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors.J. Mol. Cell. Cardiol. 30:1341-8.
Maurice. J., et al. (1999) Enhancement of cardiac function after adenoviral-mediatedin vivointracoronary beta-2 adrenergic receptor gene delivery.J. Clin. Invest. 104:21-9.
Miyamoto, M.I., et al. (2000) Adenoviral gene transfer of SERCA2a improves left- ventricular function in aortic-banded rats in transition to heart failure.Proc. Natl. Acad. Sci. USA. 97:793-98.
Mohri, H. et al. (1969) Method of surface-induced deep hypothermia for open-heart surgery in infants.J. Thorac. Cardiovasc. Surg. 58:262-70.
Nigro, V., et al. (1997) Identification of the Syrian hanster cardiomyopathy gene.Hum. Mol. Genet. 6:601-7.
Ryoke, T., et al. (1999) Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.Circulation. 100:1734-43.
Sakamoto, A., et al. (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation in the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex.Proc. Natl. Sci. USA. 94:1387-8.
Shah, A.S. et al. (2001) In vico ventricular gene delivery of a β-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.Circulation103:1311.
Svensson, E.C., et al. (1999) Efficient and stable transduction of cardiomyocytes after intramyocardial infection or intracoronary perfusion with recombinant adeno-associated virus vectors.Circulation. 99:201-5.
Toyofuku, E., et al. (1994) Amino acids Glu2 to Ile 18 in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+—ATPase of the sarcoplasmic reticulum. 269:3088-94.
Xiao, X., Li, J., and Samulski, R.J. (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper virus.J. Virol. 72:2224-32.
Chien Kenneth R.
Hoshijma Masahiko
Ikeda Yasuhiro
Ross, Jr. John
DLA Piper (US) LLP
Kaushal Sumesh
The Regents of the University of California
LandOfFree
Methods for cardiac gene transfer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for cardiac gene transfer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for cardiac gene transfer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2783658